AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20456065 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane (awake removal)
Number of subjects: 400
Study 20456065 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane (deep anesthesia removal)
Number of subjects: 400
Study 18221346 — intervention group
Group type: EXPERIMENTAL
Intervention: Incredible Years (IY) Teacher Classroom Management and Child Social and Emotion curriculum (Dinosaur School)
Number of subjects: 1768
Study 18221346 — intervention group
Group type: COMPARATOR
Intervention: Control group (matched pairs of schools)
Number of subjects: 1768
Study 15752125 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical calcipotriol (0.005%) applied twice daily
Number of subjects: 20
Study 15752125 — intervention group
Group type: COMPARATOR
Intervention: Narrow-band UVB phototherapy
Number of subjects: 20
Study 12750166 — intervention group
Group type: EXPERIMENTAL
Intervention: rhAPC (24 microg/kg per hour)
Number of subjects: 24
Study 12750166 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 11105478 — intervention group
Group type: EXPERIMENTAL
Intervention: Just deserts motive for punishment
Number of subjects: 0
Study 11105478 — intervention group
Group type: COMPARATOR
Intervention: Likelihood of committing future offenses
Number of subjects: 0
Study 11105478 — intervention group
Group type: EXPERIMENTAL
Intervention: Brain tumor identified as cause of violent action
Number of subjects: 0
Study 8873178 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific plus variable group (practised at the target distance and at distances around the target)
Number of subjects: 26
Study 8873178 — intervention group
Group type: COMPARATOR
Intervention: Specific group (practised only at the specified target distance)
Number of subjects: 26
Study 1514500 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg nifedipine
Number of subjects: 30
Study 1514500 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg nifedipine
Number of subjects: 30
Study 1514500 — intervention group
Group type: COMPARATOR
Intervention: Placebo (matched to nifedipine doses)
Number of subjects: 30
Study 6469553 — intervention group
Group type: EXPERIMENTAL
Intervention: Clorurated aminoacid solution (10% solution, 1 liter daily)
Number of subjects: 10
Study 6469553 — intervention group
Group type: COMPARATOR
Intervention: Acetated aminoacid solution (10% solution, 1 liter daily)
Number of subjects: 10
Study 31448837 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP (scaling and root planning)
Number of subjects: 24
Study 31448837 — intervention group
Group type: COMPARATOR
Intervention: SRP + AM (375 mg amoxicillin and 250 mg metronidazole, 8/8 hours, 7 days)
Number of subjects: 24
Study 28826825 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline-streptomycin-hydroxychloroquine (DSH)
Number of subjects: 177
Study 28826825 — intervention group
Group type: COMPARATOR
Intervention: Doxycycline-streptomycin (DS)
Number of subjects: 177
Study 27505191 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational video about generic medicines
Number of subjects: 70
Study 27505191 — intervention group
Group type: EXPERIMENTAL
Intervention: Generic ibuprofen
Number of subjects: 70
Study 27505191 — intervention group
Group type: COMPARATOR
Intervention: Control video
Number of subjects: 70
Study 24618349 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored intervention (n=10)
Number of subjects: 69
Study 24618349 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored intervention (n=7)
Number of subjects: 69
Study 24618349 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored intervention
Number of subjects: 69
Study 24618349 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 69
Study 24618349 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 69
Study 22591195 — intervention group
Group type: EXPERIMENTAL
Intervention: CK‐2017357 at 250 mg
Number of subjects: 67
Study 22591195 — intervention group
Group type: EXPERIMENTAL
Intervention: CK‐2017357 at 500 mg
Number of subjects: 67
Study 22591195 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study 20177164 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBO therapy)
Number of subjects: 0
Study 20177164 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 18070263 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical pathways (CP)
Number of subjects: 115
Study 15290118 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetrahydrobiopterin (BH4) 10 mg kg(‐1) body weight over 30 min
Number of subjects: 19
Study 15290118 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetrahydrobiopterin (BH4)
Number of subjects: 19
Study 15290118 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 19
Study 15290118 — intervention group
Group type: COMPARATOR
Intervention: Control group (hypercholesterolaemic subjects)
Number of subjects: 19
Study 12013167 — intervention group
Group type: EXPERIMENTAL
Intervention: Sharp expansion
Number of subjects: 945
Study 12013167 — intervention group
Group type: COMPARATOR
Intervention: Blunt expansion
Number of subjects: 945
Study 10202392 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 g mixed tea oral administration and topical treatment
Number of subjects: 59
Study 10202392 — intervention group
Group type: COMPARATOR
Intervention: Placebo and glycerin treatment
Number of subjects: 59
Study 8748361 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutamine-supplemented enteral nutrition (0.35 g of glutamine/kg body weight per day)
Number of subjects: 30
Study 8748361 — intervention group
Group type: COMPARATOR
Intervention: Isonitrogenous formula (0.05 g of glutamine/kg body weight per day)
Number of subjects: 30
Study 8748361 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutamine-supplemented enteral nutrition
Number of subjects: 30
Study 8748361 — intervention group
Group type: COMPARATOR
Intervention: Isonitrogenous formula
Number of subjects: 30
Study 2220176 — intervention group
Group type: EXPERIMENTAL
Intervention: Norethisterone acetate (NEA) therapy, 50 mg/day for 6 months followed by a 6-month pause, continued for up to 5 years post-op.
Number of subjects: 196
Study 2220176 — intervention group
Group type: COMPARATOR
Intervention: Control group (no NEA therapy) after surgery.
Number of subjects: 196
Study 2220176 — intervention group
Group type: COMPARATOR
Intervention: Control group (no NEA therapy) after irradiation.
Number of subjects: 196
Study 2220176 — intervention group
Group type: EXPERIMENTAL
Intervention: Norethisterone acetate (NEA) therapy.
Number of subjects: 196
Study 730416 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiloride (5 mg)
Number of subjects: 96
Study 730416 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (50 mg)
Number of subjects: 96
Study 730416 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide + Amiloride (50 + 5 mg)
Number of subjects: 96
Study 730416 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study 30626425 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood plasma levels of Ang-2, FGF-2, HGF, VEGF, PDGF-β, IL-8, TNF-α, TIMP-1, and TIMP-2 determined at diagnosis
Number of subjects: 0
Study 30626425 — intervention group
Group type: EXPERIMENTAL
Intervention: FGF-2, HGF, VEGF, and PDGF-β plasma levels at diagnosis
Number of subjects: 0
Study 30626425 — intervention group
Group type: EXPERIMENTAL
Intervention: Stratification based on levels of CAFs at diagnosis and their variations after therapy
Number of subjects: 0
Study 29980224 — intervention group
Group type: EXPERIMENTAL
Intervention: Decrease in daily GH dose (IGF‐1 target level of -2 to -1 SDS)
Number of subjects: 32
Study 29980224 — intervention group
Group type: COMPARATOR
Intervention: Increase in daily GH dose (IGF‐1 target level of 1 to 2 SDS)
Number of subjects: 32
Study 29980224 — intervention group
Group type: EXPERIMENTAL
Intervention: Decrease in IGF‐1 levels in females within the low treatment arm
Number of subjects: 32
Study 27713968 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole natural almonds (42 g per day)
Number of subjects: 18
Study 27713968 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole roasted almonds (42 g per day)
Number of subjects: 18
Study 27713968 — intervention group
Group type: EXPERIMENTAL
Intervention: Chopped almonds (42 g per day)
Number of subjects: 18
Study 27713968 — intervention group
Group type: EXPERIMENTAL
Intervention: Almond butter (42 g per day)
Number of subjects: 18
Study 27713968 — intervention group
Group type: COMPARATOR
Intervention: Control (0 g per day)
Number of subjects: 18
Study 24585791 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Ravitch repair (Group A)
Number of subjects: 31
Study 24585791 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-assisted thoracoscopic repair using metal stabilizers (Group B)
Number of subjects: 31
Study 24585791 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-assisted thoracoscopic repair using absorbable stabilizers (Group C)
Number of subjects: 31
Study 24585791 — intervention group
Group type: COMPARATOR
Intervention: Open surgical repair (Group A)
Number of subjects: 31
Study 22322237 — intervention group
Group type: EXPERIMENTAL
Intervention: Terlipressin (group A, N=23)
Number of subjects: 46
Study 22322237 — intervention group
Group type: EXPERIMENTAL
Intervention: Noradrenaline (group B, N=23)
Number of subjects: 46
Study 22322237 — intervention group
Group type: COMPARATOR
Intervention: Terlipressin (group A)
Number of subjects: 46
Study 22322237 — intervention group
Group type: COMPARATOR
Intervention: Noradrenaline (group B)
Number of subjects: 46
Study 22322237 — intervention group
Group type: EXPERIMENTAL
Intervention: Noradrenaline
Number of subjects: 46
Study 19919888 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentax-AWS®
Number of subjects: 32
Study 19919888 — intervention group
Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 32
Study 17397559 — intervention group
Group type: EXPERIMENTAL
Intervention: HMR Calorie System training
Number of subjects: 44
Study 16619162 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual phenotype interpretation arm
Number of subjects: 318
Study 16619162 — intervention group
Group type: COMPARATOR
Intervention: Rule-based interpretation arm
Number of subjects: 318
Study 12144196 — intervention group
Group type: EXPERIMENTAL
Intervention: Prospective observational studies of confirmed bites with correct identification of the creature.
Number of subjects: 0
Study 12144196 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaboration between biologists/taxonomists and clinical management services.
Number of subjects: 0
Study 12144196 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine follow-up of patients after bites.
Number of subjects: 0
Study 12144196 — intervention group
Group type: EXPERIMENTAL
Intervention: Analysis of databases from prospective studies.
Number of subjects: 0
Study 10517189 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifampicin 600 mg/day and doxycycline 200 mg/day for 45 days (group 1)
Number of subjects: 40
Study 10517189 — intervention group
Group type: COMPARATOR
Intervention: Rifampicin 600 mg/day and ciprofloxacin 1 g/day for 30 days (group 2)
Number of subjects: 40
Study 8748595 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal cord stimulation
Number of subjects: 27
Study 8748595 — intervention group
Group type: COMPARATOR
Intervention: Reoperation
Number of subjects: 27
Study 2044726 — intervention group
Group type: EXPERIMENTAL
Intervention: Epirubicin
Number of subjects: 24
Study 2044726 — intervention group
Group type: COMPARATOR
Intervention: Doxorubicin
Number of subjects: 24
Study 6284840 — intervention group
Group type: COMPARATOR
Intervention: Enhanced monocyte and neutrophil ADCC in patients with severe psoriasis
Number of subjects: 0
Study 6284840 — intervention group
Group type: COMPARATOR
Intervention: Normal basal cAMP levels and cAMP responses during ADCC reaction
Number of subjects: 0
Study 6284840 — intervention group
Group type: COMPARATOR
Intervention: Normal degranulation as determined by lysozyme release during ADCC
Number of subjects: 0
Study 6284840 — intervention group
Group type: COMPARATOR
Intervention: Increased hexose monophosphate shunt activation in effector cells during cytotoxic reaction
Number of subjects: 0
Study 6284840 — intervention group
Group type: COMPARATOR
Intervention: Normal activity of enzymes responsible for respiratory burst
Number of subjects: 0
Study 6284840 — intervention group
Group type: COMPARATOR
Intervention: Normal oxygen consumption and degranulation following phagocytosis of opsonized zymosan particles in neutrophils
Number of subjects: 0
Study 6284840 — intervention group
Group type: COMPARATOR
Intervention: Increased binding of IgG-sensitized erythrocytes by monocytes
Number of subjects: 0
Study 30944968 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral dissolution therapy (ODT)
Number of subjects: 150
Study 30944968 — intervention group
Group type: EXPERIMENTAL
Intervention: Shock wave lithotripsy (SWL)
Number of subjects: 150
Study 30944968 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined SWL and ODT
Number of subjects: 150
Study 30944968 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment (ODT + SWL)
Number of subjects: 150
Study 30536479 — intervention group
Group type: EXPERIMENTAL
Intervention: cis100+RT (high-dose cisplatin 100 mg/m2 on days 1, 22, and 43)
Number of subjects: 62
Study 30536479 — intervention group
Group type: COMPARATOR
Intervention: cis40+ART (intermediate-dose cisplatin weekly 40 mg/m2)
Number of subjects: 62
Study 28191913 — intervention group
Group type: EXPERIMENTAL
Intervention: LY2409021 20 mg
Number of subjects: 270
Study 28191913 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 270
Study 25824211 — intervention group
Group type: EXPERIMENTAL
Intervention: Oritavancin 1,200 mg single dose
Number of subjects: 297
Study 25824211 — intervention group
Group type: EXPERIMENTAL
Intervention: Population pharmacokinetic model
Number of subjects: 297
Study 23516964 — intervention group
Group type: EXPERIMENTAL
Intervention: Noise masker
Number of subjects: 55
Study 23516964 — intervention group
Group type: EXPERIMENTAL
Intervention: Babble masker
Number of subjects: 55
Study 23516964 — intervention group
Group type: EXPERIMENTAL
Intervention: Both conditions (noise and babble)
Number of subjects: 55
Study 21851906 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline 400 mg three times daily for 14 days
Number of subjects: 40
Study 21851906 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 21851906 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline 400 mg
Number of subjects: 40
Study 19724269 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive GMA (two sessions per week)
Number of subjects: 163
Study 19724269 — intervention group
Group type: COMPARATOR
Intervention: Routine weekly GMA (one session per week)
Number of subjects: 163
Study 17953333 — intervention group
Group type: EXPERIMENTAL
Intervention: Rocuronium
Number of subjects: 60
Study 17953333 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisatracurium
Number of subjects: 60
Study 17953333 — intervention group
Group type: EXPERIMENTAL
Intervention: Neostigmine plus atropine
Number of subjects: 60
Study 17953333 — intervention group
Group type: COMPARATOR
Intervention: Normal saline solution (placebo)
Number of subjects: 60
Study 15476756 — intervention group
Group type: EXPERIMENTAL
Intervention: Stage-Matched Intervention (SMI) for 3 months
Number of subjects: 45
Study 15476756 — intervention group
Group type: COMPARATOR
Intervention: Usual educational advice
Number of subjects: 45
Study 10665129 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 micrograms ipratropium bromide plus 2 puffs placebo
Number of subjects: 27
Study 10665129 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 micrograms formoterol fumarate plus 3 puffs placebo
Number of subjects: 27
Study 10665129 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 micrograms ipratropium
Number of subjects: 27
Study 10665129 — intervention group
Group type: EXPERIMENTAL
Intervention: 24 micrograms formoterol plus 2 puffs placebo
Number of subjects: 27
Study 10665129 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 micrograms formoterol plus 40 micrograms ipratropium plus 1 puff placebo
Number of subjects: 27
Study 10665129 — intervention group
Group type: COMPARATOR
Intervention: 4 puffs placebo
Number of subjects: 27
Study 8922243 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation therapy (RT) alone
Number of subjects: 0
Study 8922243 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy and limited field irradiation
Number of subjects: 0
Study 8922243 — intervention group
Group type: COMPARATOR
Intervention: Staging laparotomy and splenectomy
Number of subjects: 0
Study 8922243 — intervention group
Group type: COMPARATOR
Intervention: Combined chemotherapy and RT
Number of subjects: 0
Study 1919695 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperventilation (PaCO2 25 +/- 2 mm Hg)
Number of subjects: 113
Study 1919695 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperventilation plus THAM (PaCO2 25 +/- 2 mm Hg)
Number of subjects: 113
Study 1919695 — intervention group
Group type: COMPARATOR
Intervention: Normal ventilation (PaCO2 35 +/- 2 mm Hg)
Number of subjects: 113
Study 1919695 — intervention group
Group type: COMPARATOR
Intervention: Control group (Normal ventilation)
Number of subjects: 113
Study 6354209 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 mg tolbutamide injected i.v. every four hours
Number of subjects: 4
Study 31068943 — intervention group
Group type: EXPERIMENTAL
Intervention: miR-155-5p expression pre-transplantation
Number of subjects: 145
Study 31068943 — intervention group
Group type: EXPERIMENTAL
Intervention: miR-181a-5p expression pre-transplantation
Number of subjects: 145
Study 31068943 — intervention group
Group type: EXPERIMENTAL
Intervention: miR-181a-5p, miR-155-5p, and miR-122-5p expression post-transplantation
Number of subjects: 145
Study 31068943 — intervention group
Group type: EXPERIMENTAL
Intervention: miR-181a-5p expression post-transplantation
Number of subjects: 145
Study 31068943 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of miR-181a-5p and miR-155-5p expression post-transplantation
Number of subjects: 145
Study 29463278 — intervention group
Group type: EXPERIMENTAL
Intervention: medialized bilateral screw pedicel fixation (mPACT)
Number of subjects: 154
Study 29463278 — intervention group
Group type: COMPARATOR
Intervention: traditional trajectory for lumbar pedicle screw placement
Number of subjects: 154
Study 26367500 — intervention group
Group type: EXPERIMENTAL
Intervention: CYP2D6*5
Number of subjects: 133
Study 26367500 — intervention group
Group type: EXPERIMENTAL
Intervention: CYP2D6*14
Number of subjects: 133
Study 26367500 — intervention group
Group type: EXPERIMENTAL
Intervention: SLCO1B1 rs4149056
Number of subjects: 133
Study 26367500 — intervention group
Group type: EXPERIMENTAL
Intervention: ABCG2 rs2231142
Number of subjects: 133
Study 26367500 — intervention group
Group type: EXPERIMENTAL
Intervention: CYP2D6*41
Number of subjects: 133
Study 26367500 — intervention group
Group type: EXPERIMENTAL
Intervention: SLCO1B1 rs4149015
Number of subjects: 133
Study 23194256 — intervention group
Group type: EXPERIMENTAL
Intervention: Technology-supported behavioral weight loss (TECH)
Number of subjects: 96
Study 23194256 — intervention group
Group type: COMPARATOR
Intervention: Standard behavioral weight loss (STND)
Number of subjects: 96
Study 23194256 — intervention group
Group type: COMPARATOR
Intervention: Self-guided behavioral weight loss (SELF)
Number of subjects: 96
Study 20193974 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes patients
Number of subjects: 25
Study 20193974 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 25
Study 18580589 — intervention group
Group type: EXPERIMENTAL
Intervention: Panax ginseng powder (4.5 g/d) for 12 weeks
Number of subjects: 97
Study 18580589 — intervention group
Group type: COMPARATOR
Intervention: Control group (no ginseng treatment)
Number of subjects: 97
Study 15778567 — intervention group
Group type: EXPERIMENTAL
Intervention: Empowerment Program
Number of subjects: 0
Study 12376221 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravesicle 4% formalin instillation (Group I)
Number of subjects: 19
Study 12376221 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic placement of 10% formalin-soaked pledgets (Group II)
Number of subjects: 19
Study 10325267 — intervention group
Group type: EXPERIMENTAL
Intervention: Hysteroscopic scissors with a specially designed uterine balloon catheter
Number of subjects: 14
Study 10325267 — intervention group
Group type: EXPERIMENTAL
Intervention: Microlaparoscopy scissors with a cervical cannula
Number of subjects: 14
Study 8757031 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical magnetic stimulation with a butterfly-shaped magnetic coil at 1-cm intervals, constant output, and random order.
Number of subjects: 6
Study 8757031 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical magnetic stimulation with a butterfly-shaped magnetic coil.
Number of subjects: 6
Study 1673051 — intervention group
Group type: EXPERIMENTAL
Intervention: Buflomedil
Number of subjects: 31
Study 1673051 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 6837492 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation (20 mg zinc added to vitamin and mineral supplements)
Number of subjects: 213
Study 6837492 — intervention group
Group type: COMPARATOR
Intervention: Control group (similar vitamin and mineral supplements without added zinc)
Number of subjects: 213
Study 30952500 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadrivalent meningococcal conjugate vaccine (MCV)
Number of subjects: 50
Study 29734571 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-circuit rebreather (CCR) dive (PO₂ 1.4)
Number of subjects: 6
Study 29734571 — intervention group
Group type: COMPARATOR
Intervention: CTRL (breathing air)
Number of subjects: 6
Study 27081191 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexcom G4 continuous glucose monitoring (CGM)
Number of subjects: 161
Study 27081191 — intervention group
Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 161
Study 27081191 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexcom G4 CGM
Number of subjects: 161
Study 24498023 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine (dopaminergic agonist)
Number of subjects: 0
Study 22188747 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical capsaicin (200 μl, 5%)
Number of subjects: 22
Study 20171421 — intervention group
Group type: EXPERIMENTAL
Intervention: Test formulation of clopidogrel 75-mg tablets
Number of subjects: 24